Study on Hyperlipidemia Combined With Carotid Atherosclerosis With ShenJu Granules

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This study focuses on PWV as the main outcome, aiming to evaluate the efficacy and safety of ShenJu in treating patients with hyperlipidemia combined with carotid atherosclerosis, and provide a basis for traditional Chinese medicine treatment of hyperlipidemia combined with carotid atherosclerosis.
Epistemonikos ID: c07c35f958435ca46c22cd1f1e048a7e34ea3019
First added on: May 15, 2024